Gary Zammit Selected Research

Zolpidem (Ambien)

1/2021	Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder.
1/2020	Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder.
12/2019	Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
2/2009	Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia.
1/2009	Comparative tolerability of newer agents for insomnia.
6/2008	A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary Zammit Research Topics

Disease

23	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2006
5	Sleepiness 01/2022 - 12/2014
3	Headache (Headaches) 03/2021 - 12/2014
2	Obstructive Sleep Apnea 01/2022 - 01/2021
2	Nausea 03/2021 - 03/2006
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Death (Near-Death Experience) 01/2022
1	Narcolepsy 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Fatigue 01/2020
1	Nasopharyngitis 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 03/2015
1	Sleep Deprivation 10/2014
1	Infections 02/2014
1	Myocardial Infarction 09/2012
1	Stroke (Strokes) 09/2012
1	Apnea 01/2012
1	Dizziness (Lightheadedness) 03/2006

Drug/Important Bio-Agent (IBA)

10	Orexin Receptor AntagonistsIBA 01/2022 - 10/2015
6	lemborexantIBA 07/2021 - 11/2017
6	Zolpidem (Ambien)FDA LinkGeneric 01/2021 - 06/2008
6	ramelteon (Rozerem)FDA Link 04/2009 - 01/2006
3	daridorexantIBA 01/2022 - 01/2020
2	almorexantIBA 08/2017 - 02/2017
2	Antidepressive Agents (Antidepressants)IBA 10/2016 - 03/2015
2	Hypnotics and Sedatives (Sedatives)IBA 10/2016 - 01/2009
2	Modafinil (Provigil)FDA Link 12/2014 - 10/2014
2	Lisdexamfetamine Dimesylate FDA Link 12/2014 - 10/2014
2	Eszopiclone (Lunesta)FDA Link 01/2009 - 06/2008
2	Melatonin Receptors (Melatonin Receptor)IBA 01/2009 - 01/2009
2	MT2 Melatonin ReceptorIBA 08/2007 - 01/2006
1	solriamfetolIBA 01/2022
1	ASP8062IBA 03/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Diphenhydramine (Benadryl)FDA LinkGeneric 11/2019
1	OrexinsIBA 08/2017
1	SaltsIBA 10/2016
1	Mirtazapine (Rexer)FDA LinkGeneric 10/2016
1	maleic acid (maleate)IBA 10/2016
1	Lurasidone Hydrochloride FDA Link 01/2016
1	suvorexantIBA 10/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2015
1	Biogenic Amines (Biogenic Amine)IBA 03/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2015
1	Hemoglobins (Hemoglobin)IBA 01/2012
1	LipidsIBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	BenzodiazepinesIBA 01/2009
1	zopiclone (Zop)IBA 01/2009
1	zaleplon (Sonata)FDA LinkGeneric 01/2009
1	Tiagabine (Gabitril)FDA Link 03/2006

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 07/2021
1	Oral Administration 02/2017
1	Device Removal (Removal, Device) 02/2014
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2012
1	Percutaneous Coronary Intervention 09/2012
1	Carotid Endarterectomy 09/2012